Rising patient interest in TRT, GLP-1s, and peptide stacking requires clinicians to anchor conversations in evidence tiers, use baseline DEXA scans to monitor body composition, and engage patient goals without endorsing unsupported claims.
|Videos|May 5, 2022
Study reveals 20-year data on inflatable penile prostheses
Author(s)Urology Times staff
“For the first time, we have 20-year follow-up data after the penile prosthesis,” says Mohit Khera, MD, MBA, MPH.
Advertisement
In this video, Mohit Khera, MD, MBA, MPH, discusses the background, key findings, and take-home messages from the recent Urology study, “Long-term Survival Rates of Inflatable Penile Prostheses: Systematic Review and Meta-Analysis,” for which he served as a study author. Khera is a professor and the F. Brantley Scott Chair in Urology at Baylor College of Medicine in Houston, Texas.
Advertisement
Related to this article
Eugene Cone, MD, discusses recombinant BCG for NMIBC, including ongoing clinical evaluation and its potential to address ongoing BCG supply challenges.
Eugene Cone, MD, discusses SWOG S1602 findings comparing Tokyo-172 and TICE BCG and the potential role of alternative BCG strains in NMIBC
Juan Gómez-Rivas, MD, discusses barriers to PSMA-PET imaging and how disparities in access may affect prostate cancer staging and treatment planning.
Jonathan Harper, MD, discusses findings from the PUSH trial may inform counseling on hydration and stone recurrence.
Cameron C. Jones, MD, discusses patient selection for Aquablation, including prostate size, anatomy, and factors that may favor alternative BPH procedures.
Andrew Peterson, MD, discusses the quality-of-life impact of post-cancer incontinence and advances in electronically controlled artificial urinary sphincters.
John P. Sfakianos, MD, discusses the challenges of managing recurrent LG-IR-NMIBC and the role of chemoablation.
Advertisement
Advertisement
Trending on Urology Times
1
Evidence for Combining Prostatic Urethral Lift With Radiotherapy
2
Chemoablation expands treatment options for recurrent LG-IR-NMIBC
3
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
4
Network meta-analysis ranks neoadjuvant options in cisplatin-eligible MIBC
5